Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
about
Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable EpilepsyCombined effects of epileptic seizure and phenobarbital induced overexpression of P-glycoprotein in brain of chemically kindled ratsDrug-Resistant Epilepsy: Multiple Hypotheses, Few AnswersABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.Advancing the medical management of epilepsy: disease modification and pharmacogenetics.Drug resistance in cortical and hippocampal slices from resected tissue of epilepsy patients: no significant impact of p-glycoprotein and multidrug resistance-associated proteinsPotential role of drug transporters in the pathogenesis of medically intractable epilepsy.The role of common variation in drug transporter genes in refractory epilepsy.Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications.A novel positron emission tomography imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood-brain barrierABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.One of the hottest topics in epileptology: ABC proteins. Their inhibition may be the future for patients with intractable seizures.Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier.Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions.Intractable epilepsy and the P-glycoprotein hypothesis.Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.The Role of Drug-resistance Proteins in Medically Refractory Epilepsy.Upregulation of Multidrug Resistance Transporters in the Epileptic Brain.P-glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes.Membrane Transporters and Pharmacological ImplicationsExpression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy.Drug transporters are altered in brain, liver and kidney of rats with chronic epilepsy induced by lithium-pilocarpine.Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain.Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex.A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine.Influence of lamotrigine and topiramate on MDR1 expression in difficult-to-treat temporal lobe epilepsy.Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy.
P2860
Q26780520-D4BBB8DA-9FDF-4F46-9A2E-56AC5BF3FB76Q33772891-A60C5CE7-F9B0-4179-8E0E-E2F12E03ADF3Q33875271-BD713357-4F15-4806-B397-5CF8477F51B0Q33938893-A11826BC-7E33-4FF2-ABC6-047812BA2969Q33985133-DC458691-DB40-4A42-829E-27C30419B216Q34579490-4F6AE791-C0AE-4332-BA53-0F86CD18BB21Q35094603-402CC287-4E6D-4423-8983-A487BBFF1B7EQ36023613-271243DB-4410-429F-A5B9-423036026D16Q36192748-E76AE25B-9E12-4BE5-821F-F4D76835A140Q36555922-540F4B4D-945F-42BF-BFE0-8AFC5E09B9A1Q36955931-5F1AEEA7-F0CC-49FF-87ED-E2D65FC20CDDQ36957955-1FDF9D35-8E60-46A4-B67E-704E4A6AD3C1Q37204397-7A7A315A-7E45-4A41-BDF6-02EA121161EDQ37855817-194F8B9C-31CD-4943-94EE-C2DBB126F5D9Q37873936-7F2505A5-7C3E-444B-9287-954A00704384Q38497941-99BD9DD9-DDDC-40F8-A58F-07584F4CE59AQ38984309-FCD2B8ED-98AC-4285-9A12-2CE0B9099CB6Q40466671-1DF140C5-AD39-4BD1-A4D0-813150EB5E03Q40467258-505B1C8B-558C-4CB8-BEDD-3821867BFF38Q40736811-071E277F-DEAC-462D-9B29-6665637713B3Q41022921-CB2712EB-5FA8-4CDA-9D77-902E7DBDA771Q44854306-9AEA5D10-3304-4F53-8A6F-187ABF915F53Q44998746-D366E585-EB3E-40A2-89D8-911C33DCE1D0Q46536800-8EC01611-1911-4422-883B-047A73375D63Q46646341-1314ECB0-65A9-4E8F-8984-4F5681EA36B0Q46725875-73547E6B-29A2-4A6A-ADFA-F9EAA30F43DEQ46962015-80282001-0ACC-4A56-9E32-E776D9246578Q48669608-CA34E17A-6C5F-4712-8870-D89C1B0F5F33
P2860
Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
@ast
Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
@en
Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
@nl
type
label
Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
@ast
Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
@en
Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
@nl
prefLabel
Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
@ast
Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
@en
Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
@nl
P2093
P3181
P1433
P1476
Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
@en
P2093
A Lazarowski
A Rabinowicz
A Taratuto
G Sevlever
P3181
P356
10.1016/S0887-8994(99)00074-0
P407
P577
1999-10-01T00:00:00Z